Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shamaila Munir

Showing results (1-10 of 31) with videos related to

Pageof 4
Sort By:
Oncoimmunology|June 5, 2013
The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4<sup>+</sup> T cellsShamaila Munir, Gitte Holmen Andersen, Inge Marie Svane, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2016
PD-L1-specific T cellsShamaila Munir Ahmad, Troels Holz Borch, Morten Hansen, et al.
Cellular & Molecular Immunology|May 12, 2019
Peripheral memory T cells specific for Arginase-1Evelina Martinenaite, Shamaila Munir Ahmad, Inge Marie Svane, et al.
Oncoimmunology|December 18, 2012
Characterization of T-cell responses against IκBα in cancer patientsShamaila Munir, Thomas Mørch Frøsig, Morten Hansen, et al.
The Journal of Investigative Dermatology|April 20, 2012
A promiscuous survivin-derived T-cell epitope restricted to the HLA-A3 super-type allelesNiels Junker, Shamaila Munir, Pia Kvistborg, et al.
Signal Transduction and Targeted Therapy|June 23, 2026
Engineering T cells with a novel PD-L1-specific TCR targeting immune and cancer cellsThomas Landkildehus Lisle, Emilie Bülow Jacobsen, Shamaila Munir Ahmad, et al.
Stem Cell Investigation|January 13, 2017
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trialNicolai Grønne Jørgensen, Shamaila Munir Ahmad, Niels Abildgaard, et al.
Cancer Immunology, Immunotherapy : CII|November 7, 2019
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitopeEvelina Martinenaite, Shamaila Munir Ahmad, Simone Kloch Bendtsen, et al.
Oncoimmunology|May 12, 2015
Spontaneous presence of FOXO3-specific T cells in cancer patientsStine Kiaer Larsen, Shamaila Munir Ahmad, Manja Idorn, et al.
Cancer Research|July 18, 2015
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor ReactivityMarco Donia, Rikke Andersen, Julie W Kjeldsen, et al.
Pageof 4

Showing results (1-10 of 31) with videos related to

Sort By:
Pageof 4
Oncoimmunology|June 5, 2013
The immune checkpoint regulator PD-L1 is a specific target for naturally occurring CD4<sup>+</sup> T cellsShamaila Munir, Gitte Holmen Andersen, Inge Marie Svane, et al.
Cancer Immunology, Immunotherapy : CII|January 4, 2016
PD-L1-specific T cellsShamaila Munir Ahmad, Troels Holz Borch, Morten Hansen, et al.
Cellular & Molecular Immunology|May 12, 2019
Peripheral memory T cells specific for Arginase-1Evelina Martinenaite, Shamaila Munir Ahmad, Inge Marie Svane, et al.
Oncoimmunology|December 18, 2012
Characterization of T-cell responses against IκBα in cancer patientsShamaila Munir, Thomas Mørch Frøsig, Morten Hansen, et al.
The Journal of Investigative Dermatology|April 20, 2012
A promiscuous survivin-derived T-cell epitope restricted to the HLA-A3 super-type allelesNiels Junker, Shamaila Munir, Pia Kvistborg, et al.
Signal Transduction and Targeted Therapy|June 23, 2026
Engineering T cells with a novel PD-L1-specific TCR targeting immune and cancer cellsThomas Landkildehus Lisle, Emilie Bülow Jacobsen, Shamaila Munir Ahmad, et al.
Stem Cell Investigation|January 13, 2017
Peptide vaccination against multiple myeloma using peptides derived from anti-apoptotic proteins: a phase I trialNicolai Grønne Jørgensen, Shamaila Munir Ahmad, Niels Abildgaard, et al.
Cancer Immunology, Immunotherapy : CII|November 7, 2019
Arginase-1-based vaccination against the tumor microenvironment: the identification of an optimal T-cell epitopeEvelina Martinenaite, Shamaila Munir Ahmad, Simone Kloch Bendtsen, et al.
Oncoimmunology|May 12, 2015
Spontaneous presence of FOXO3-specific T cells in cancer patientsStine Kiaer Larsen, Shamaila Munir Ahmad, Manja Idorn, et al.
Cancer Research|July 18, 2015
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor ReactivityMarco Donia, Rikke Andersen, Julie W Kjeldsen, et al.
Pageof 4